Hofseth BioCare ASA (FRA:HBQ)
Germany flag Germany · Delayed Price · Currency is EUR
0.0944
+0.0030 (3.28%)
At close: Feb 20, 2026

Hofseth BioCare ASA Cash Flow Statement

Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-134.88-125.3-106.68-137.39-126.46
Depreciation & Amortization
39.4132.7929.8724.4125.72
Other Amortization
-6.996.545.813.63
Loss (Gain) From Sale of Assets
--8.12-23.49--
Asset Writedown & Restructuring Costs
---0.19-
Loss (Gain) on Equity Investments
-2.157.482.54-0.2-0.03
Other Operating Activities
77.44159.689.499.959.39
Change in Accounts Receivable
-2.67-4-0.78-3.984.18
Change in Inventory
-3.9126.6333.98-25.71-17.51
Change in Accounts Payable
0.9938.47-90.5970.3639.21
Change in Other Net Operating Assets
10.16-144.4141.8711.40.1
Operating Cash Flow
-15.61-9.782.76-45.17-61.78
Capital Expenditures
-25.31-2.44-8.19-4.02-22.92
Sale (Purchase) of Intangibles
-0.73-1.63-5.87-13.76-14.83
Investment in Securities
---1.62--0.19
Other Investing Activities
--00.69--
Investing Cash Flow
-26.04-4.07-14.99-17.78-37.94
Short-Term Debt Issued
-19.428.35--
Long-Term Debt Issued
133.4625.1--1.09
Total Debt Issued
133.4644.528.35-1.09
Long-Term Debt Repaid
-26.36-12.98-14.18-15.05-14.89
Net Debt Issued (Repaid)
107.1131.5214.17-15.05-13.8
Issuance of Common Stock
---70.78-
Other Financing Activities
-23.98-15.98-10.48-10.28-9.39
Financing Cash Flow
83.1315.543.6945.45-23.2
Miscellaneous Cash Flow Adjustments
-0--0
Net Cash Flow
41.471.69-8.54-17.49-122.91
Free Cash Flow
-40.92-12.22-5.43-49.19-84.7
Free Cash Flow Margin
-15.96%-4.60%-2.49%-40.84%-96.67%
Free Cash Flow Per Share
-0.10-0.03-0.01-0.13-0.24
Cash Interest Paid
22.8315.699.499.959.39
Levered Free Cash Flow
-19.5321.85-100.88-72.21-65.15
Unlevered Free Cash Flow
-5.2631.66-96.16-65.99-59.28
Change in Working Capital
4.57-83.3184.4952.0625.97
Source: S&P Global Market Intelligence. Standard template. Financial Sources.